These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
541 related items for PubMed ID: 11393778
1. The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. Fazzalari NL, Kuliwaba JS, Atkins GJ, Forwood MR, Findlay DM. J Bone Miner Res; 2001 Jun; 16(6):1015-27. PubMed ID: 11393778 [Abstract] [Full Text] [Related]
3. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones. Ikeda T, Utsuyama M, Hirokawa K. J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864 [Abstract] [Full Text] [Related]
4. Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. Tsangari H, Findlay DM, Kuliwaba JS, Atkins GJ, Fazzalari NL. Bone; 2004 Jul; 35(1):334-42. PubMed ID: 15207775 [Abstract] [Full Text] [Related]
14. Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL. Bord S, Frith E, Ireland DC, Scott MA, Craig JI, Compston JE. Bone; 2005 May; 36(5):812-9. PubMed ID: 15794927 [Abstract] [Full Text] [Related]
15. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D. Cytokine Growth Factor Rev; 2004 Dec; 15(6):457-75. PubMed ID: 15561602 [Abstract] [Full Text] [Related]
16. Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland. Hofbauer LC, Kluger S, Kühne CA, Dunstan CR, Burchert A, Schoppet M, Zielke A, Heufelder AE. J Cell Biochem; 2002 Dec; 86(4):642-50. PubMed ID: 12210731 [Abstract] [Full Text] [Related]
17. Osteoprotegerin and RANKL in alcoholic liver cirrhosis. Fábrega E, Orive A, García-Suarez C, García-Unzueta M, Antonio Amado J, Pons-Romero F. Liver Int; 2005 Apr; 25(2):305-10. PubMed ID: 15780054 [Abstract] [Full Text] [Related]
18. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation. Sun SG, Lau YS, Itonaga I, Sabokbar A, Athanasou NA. J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498 [Abstract] [Full Text] [Related]
19. Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand system in the early post-operative period of liver transplantation. Fábrega E, Orive A, García-Unzueta M, Amado JA, Casafont F, Pons-Romero F. Clin Transplant; 2006 May; 20(3):383-8. PubMed ID: 16824158 [Abstract] [Full Text] [Related]
20. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha. Wada N, Maeda H, Yoshimine Y, Akamine A. Bone; 2004 Sep; 35(3):629-35. PubMed ID: 15336598 [Abstract] [Full Text] [Related] Page: [Next] [New Search]